Temasek Holdings
http://www.temasekholdings.com.sg/Temasek Holdings is an Asian investment firm headquartered in Singapore. Its portfolio spans various industries including telecommunications & media, financial services, real estate, transportation & logistics, energy & resources, infrastructure, engineering & technology as well as bioscience & healthcare. As of March 2007, the net value of its portfolio is more than US$100 billion, concentrated principally in Singapore, Asia and the OECD economies. Temasek's total shareholder return since its inception in 1974 has been more than 18% compounded annually. It has a corporate credit rating of AAA/Aaa by rating agencies Standard & Poor's and Moody's respectively.
In December of 2007, Temasek Holdings invested $4.4 billion in Merrill Lynch (NYSE: MER) common stock.
View Older Stories View More Recent Stories
-
Ant Financial raises $14 billion in world's largest-ever single fundraising
-
Hangzhou Just Biotherapeutics Secures $35 Million Series B+ Financing
-
Impossible Foods Checks in to Hong Kong Hotels
-
New Research Shows SMB Headaches Associated With Paper Checks Continues – Many Looking to Digital Payments to Solve Pains
-
SoftBank's ARM cedes control of China ops to consortium for $775 million
-
Dutch fintech Adyen valued at up to $8.3 billion as investors seek shares
-
FX settlement provider CLS invests in blockchain consortium R3
-
Impossible Foods Hires Dana Wagner as Chief Legal Officer
-
The Impossible Burger Debuts Today At Houlihan's
-
Indonesian ride-hailing firm Go-Jek says to expand abroad
-
Poshmark Hits New Milestone as it Pays Out More Than $1 Billion to its Community of Seller Stylists
-
Form SC 13D/A AMYRIS, INC. Filed by: Temasek Holdings (Private) Ltd
-
Weyland Tech CEO Discusses AtozPay E-Wallet Beta Exit, Strategic Views on Payment Space
-
Weyland Tech CEO Discusses AtozPay E-Wallet Beta Exit, Strategic Views on Payment Space
-
Mobile payment firms struggle to dethrone cash in Southeast Asia
-
Impossible Foods Receives Kosher Certification
-
Iora Health Raises $100 Million in Series E Financing
-
Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal
-
Innovent Biologics Announces the Study Result of its Anti-PD-1 Antibody in Hodgkin Lymphoma
-
Form SC 13D/A Virtu Financial, Inc. Filed by: Temasek Holdings (Private) Ltd
-
Form 4 Virtu Financial, Inc. For: May 15 Filed by: Temasek Holdings (Private) Ltd
-
Form 13F-NT Temasek Capital (Private For: Mar 31
-
Form 13F-HR Temasek Holdings (Privat For: Mar 31
-
Form 13F-NT Temasek Life Sciences For: Mar 31
-
MediSix Therapeutics Launches with USD$20M Series A Financing
-
Virtu Financial (VIRT) Prices 15M Share Secondary Offering at $28/Sh
-
Virtu Financial Announces Pricing of its Secondary Offering
-
Puls and ANTOP Partner to Bring Same-Day Installation Services for HDTV Antennas to Los Angeles Cord Cutters
-
Akili Completes $55 Million Financing to Advance Company’s Digital Medicine Platform and Product Pipeline Aimed at Treating Cognitive Dysfunction
-
Virtu Financial (VIRT) to Offer 15M Sharesa
-
Virtu Financial Announces Commencement of Secondary Offering
-
Pluribus Networks to Participate in the Light Reading Big Communications Event
-
Sovereign funds flock to developing-world startups
-
Bill.com Appoints Seasoned Marketing and Engineering Executives to Accelerate Massive Shift From Paper to Digital Payments for Business
-
Hong Kong scrambles for talent in battle for Nasdaq's biotech crown
-
Innovent Biologics completed US$150 million Series E round financing
-
Chongqing's Jiangjin District launches investment roadshow in Singapore
-
Indonesia's Go-Jek planning Philippine expansion: regulator
-
Bill.com Named “2018 Bay Area Best Place to Work”
-
Impossible Foods Makes International Debut In Hong Kong
-
Pluribus Networks Recognized on CRN’s Software-Defined Data Center 50 List
-
Singapore to test facial recognition on lampposts, stoking privacy fears
-
The Impossible Slider Debuts at White Castle®
-
Warburg Pincus in talks to invest in Ant's $8 billion funding round: sources
-
Form SC 13G Homology Medicines, Inc. Filed by: Temasek Holdings (Private) Ltd
-
China's Ant ups fundraising target, valuation could hit $150 billion: sources
-
HNA Group Signs MOU with Temasek to Explore Business Partnerships in Aviation and Logistics
-
Temasek stake values 'Salt Bae' Turkish restaurant owner at $1.2 billion
-
Internet of Things security firm Armis raises $30 million
-
Armis Raises $30 Million to Secure Enterprise IoT

